CD79A and duodenal ulcer: Therefore, administering acid-suppressing therapy ahead of anti-Hp treatment may improve the gastric pH and compliance of patients, whilst also elevating the content of Hp-specific IgA and enhancing the sustainability, activity and efficacy of anti-Hp drugs, which is beneficial to the eradication of Hp and the healing of duodenal ulcers.